BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34859693)

  • 1. Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials.
    Flight L; Julious S; Brennan A; Todd S
    Med Decis Making; 2022 May; 42(4):461-473. PubMed ID: 34859693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive designs in critical care trials: a simulation study.
    Li W; Cornelius V; Finfer S; Venkatesh B; Billot L
    BMC Med Res Methodol; 2023 Oct; 23(1):236. PubMed ID: 37853343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of randomised controlled trials with adaptive and traditional group sequential designs - applications in cardiovascular clinical trials.
    Zhang J; Saju C
    BMC Med Res Methodol; 2023 Sep; 23(1):200. PubMed ID: 37679710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.
    Tuffaha HW; Reynolds H; Gordon LG; Rickard CM; Scuffham PA
    Clin Trials; 2014 Dec; 11(6):648-56. PubMed ID: 25084784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial.
    Forster M; Brealey S; Chick S; Keding A; Corbacho B; Alban A; Pertile P; Rangan A
    Clin Trials; 2021 Dec; 18(6):647-656. PubMed ID: 34407641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.
    Emerson SC; Rudser KD; Emerson SS
    Stat Med; 2011 May; 30(11):1199-217. PubMed ID: 21538450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-stage designs with small sample sizes.
    Kieser M; Rauch G; Pilz M
    J Biopharm Stat; 2023 Jan; 33(1):53-59. PubMed ID: 35612521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible designs by adaptive plans of generalized Pocock- and O'Brien-Fleming-type and by self-designing clinical trials.
    Hartung J
    Biom J; 2006 Aug; 48(4):521-36. PubMed ID: 16972703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-arm group sequential designs with a simultaneous stopping rule.
    Urach S; Posch M
    Stat Med; 2016 Dec; 35(30):5536-5550. PubMed ID: 27550822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trial.
    Ryan EG; Stallard N; Lall R; Ji C; Perkins GD; Gates S
    Trials; 2020 Jan; 21(1):84. PubMed ID: 31937351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs.
    Parsons NR; Stallard N; Parsons H; Haque A; Underwood M; Mason J; Khan I; Costa ML; Griffin DR; Griffin J; Beard DJ; Cook JA; Davies L; Hudson J; Metcalfe A
    BMC Med Res Methodol; 2022 Oct; 22(1):256. PubMed ID: 36183085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical rules for safety monitoring in clinical trials.
    Martens MJ; Logan BR
    Clin Trials; 2024 Apr; 21(2):152-161. PubMed ID: 37877375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.
    Ryan EG; Bruce J; Metcalfe AJ; Stallard N; Lamb SE; Viele K; Young D; Gates S
    BMC Med Res Methodol; 2019 May; 19(1):99. PubMed ID: 31088354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Bayesian and frequentist group-sequential clinical trial designs.
    Stallard N; Todd S; Ryan EG; Gates S
    BMC Med Res Methodol; 2020 Jan; 20(1):4. PubMed ID: 31910813
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.